Skip to main content

Switzerland

04
Jun 2026

First revision of the new Swiss outpatient reimbursement system submitted for approval

On June 2, 2026, OAAT AG and the tariff partners submitted the 2027 revision of the new Swiss comprehensive outpatient reimbursement system to the Federal Council for approval. The revision further develops the new system introduced in January 2026, incorporating feedback from the annual application process and focusing on updates to outpatient flat rates and TARDOC across nuclear medicine, surgery, pathology, pediatrics, and emergency care. If approved, the revised version will take effect on January 1, 2027.
12
Feb 2026

The application window for changes to the Swiss outpatient reimbursement system is open

From February 1 to April 30, 2026, the OAAT AG (the entity managing the new Swiss outpatient reimbursement system) is accepting applications for the modifications of the TARDOC and Outpatient flat rates. Submitted proposals will be reviewed within the annual tariff development process, validated by the OAAT Board of Directors, and subsequently submitted to the Federal Council for final approval and publication.
07
Jan 2026

Swiss List of Analyses updated in January 2026

On December 3, 2025, the Swiss Federal Office of Public Health announced amendments to the Healthcare Benefit Ordinance, including its Annex 3 (the List of Analysis). The modifications include the creation of a new code for Dermatophytes testing by nucleic acid amplification.
23
Dec 2025

First reimbursement category for health apps announced in Switzerland

On December 3, 2025, the Swiss Federal Office of Public Health announced amendments to the List of Medical Aids (Annex 2 of the Healthcare Benefit Ordinance or MiGeL), which will take effect in 2026. From July 1, 2026, the MiGeL List will include a new chapter for digital health applications. The first generic category to be registered covers a health application for Cognitive Behavioral Therapy for depression.
19
Dec 2025

Updates in the coverage of medical services in Switzerland in 2026

On December 3, 2025, the Swiss Federal Office of Public Health published updates to the Healthcare Benefit Ordinance (KLV/OPre), which determines coverage of medical services in Switzerland. The changes will take effect on January 1, 2026, and relate to prophylactic vaccinations, cost containment measures, and other matters. The updates are also implemented in KLV Annexes, including the List of explicitly evaluated services (Annex 1), the outpatient-before-inpatient mandate (Annex 1a), the List of Medical Aids (Annex 2, MiGeL), and the List of Analyses (Annex 3, AL).
09
Dec 2025

The 2026 final version of the SwissDRG released

On November 28, 2025, the entity managing the DRG system in Switzerland, SwissDRG, published the final (billing) version of the 2026 DRG system. In total, 19 new DRGs related to cardiovascular, ENT, gastrointestinal, neurology and neurosurgery, obstetrics and gynecology, orthopedics, and some other fields were introduced. Also, four new add-on reimbursement categories were added.
10
Nov 2025

Swiss Federal Council approves adjustments to the comprehensive outpatient reimbursement system

On November 5, 2025, the Swiss Federal Council approved a set of adjustments and additions to the new comprehensive outpatient tariff system, which comprises TARDOC and the outpatient flat rates. The implementation of changes before the system's launch on January 1, 2026, was requested by the tariff partners in July 2025. The adjustments primarily affect emergency services, oncology, wound care, and pathology.
22
Aug 2025

The 2026 version of the Swiss CHOP code classification was published

On July 31, 2025, the Swiss Federal Statistics Office (UFS) released the systematic version of the Swiss classification of surgical interventions (CHOP) for 2026. The CHOP classification is now available in German and will come into force on January 1, 2026. Multiple new procedure codes were introduced in various fields, including the cardiovascular, ENT, extracorporeal treatments, interventional radiology, nephrology and urology, orthopedics, peripheral vascular, and radionucleide therapy.